Developer docs
API playgroundTry for free, no card

Search company profiles

ADx Health

Full company profile

uuid000ddfz

Namestring
ADx Health
Legal namestring
Affirmativ Diagnostics PLLC
Websiteurl
adxhealth.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

ADx Health (legal entity: Affirmativ Diagnostics PLLC) is a privately held genetic and diagnostic testing company founded in 2016 and headquartered in Bellingham, Washington. The company operates its own CLIA-certified and CAP-accredited clinical laboratory where all testing is performed in-house, and sells primarily direct-to-consumer through an e-commerce storefront (shop.adxhealth.com), supplemented by a network of referring physicians and wellness providers who access a dedicated Provider Portal.

The product portfolio is anchored on Alzheimer's disease diagnostics and has expanded into adjacent genetic and microbiome categories. Core products include GenoRisk™, an at-home saliva-based test that uses a proprietary polygenic risk score algorithm evaluating 31 genetic variants across 23 genes (including APOE) for late-onset Alzheimer's risk; WellMind, a blood-based p-Tau217 biomarker test capable of identifying amyloid-related pathology up to 18 years before clinical diagnosis; myGenoFit (athletic performance genetics), PGxComplete (pharmacogenomics), and BiomeIQ (gut microbiome). Each purchase includes a 15-minute telehealth consultation. Underlying technology relies on DNA extraction from saliva, PCR amplification, mass spectrometry-based variant detection, and statistical cross-validation of polygenic models, supported by a peer-reviewed publication authored by Scientific Director Dr. Ryan Fortna.

The business model is one-time direct payment for test kits via e-commerce, with pay-as-you-go pricing (specific prices not publicly disclosed), bundled telehealth, and a referral-driven B2B2C layer through partner providers. The company is privately held with no disclosed funding rounds or institutional investors, operates within a U.S.-only footprint with explicit exclusions for New York state and international orders, and maintains an active content marketing and scientific advisory presence to drive demand.

Short descriptiontext

ADx Health is a Bellingham, WA-based private genetic testing company operating a CLIA-certified laboratory, selling direct-to-consumer at-home and blood-based tests for Alzheimer's risk, pharmacogenomics, athletic performance, and gut health to consumers and referring healthcare providers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBellingham, United States
HQ citystring
Bellingham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
genetic testing services, Alzheimer's diagnostics, polygenic risk scoring, direct-to-consumer testing, pharmacogenomic testing
Industry4 codes
PRIMARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • Medical and Diagnostic Laboratories62151
SIC code2 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Genetic Testing and Diagnostic Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Genetic Testing Kits
TypeOne Time License
Description

Direct-to-consumer sales of at-home genetic testing kits including GenoRisk Alzheimer's test, WellMind p-Tau217 blood test, myGenoFit athletic genetic test, and PGxComplete pharmacogenomics test. Customers purchase kits online and receive results through a secure portal with optional 15-minute telehealth consultation included.

adxhealth.com
2Telehealth Consultation Services
TypeProfessional Services
Description

Optional add-on telehealth consultation with healthcare provider to review genetic testing results. Included in test purchase at no additional cost for initial 15-minute consultation.

adxhealth.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain
Pricing details1 tier
1Genetic testing kits with included telehealth consultation
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Tests available for purchase online. Promo codes and discounts available through newsletter subscription. 15-minute telehealth consultation included with each test purchase.

adxhealth.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 5 records shown
1GenoRisk™ Alzheimer’s
Description

At-home genetic test providing a polygenic risk score for late-onset Alzheimer's disease using saliva sample

adxhealth.com
+4 more records
Core offering1 text field

ADx Health sells direct-to-consumer genetic testing and diagnostic kits, primarily focused on Alzheimer's disease risk assessment and early detection. Its flagship GenoRisk™ test uses a saliva sample to compute a polygenic risk score for late-onset Alzheimer's by evaluating 31 genetic variants across 23 genes, while its WellMind blood test measures the p-Tau217 biomarker to detect amyloid-pathology-related changes up to 18 years before clinical diagnosis. Additional offerings include the myGenoFit athletic genetics test, the PGxComplete pharmacogenomics test, and the BiomeIQ gut microbiome test, with each kit including a 15-minute telehealth consultation and results delivered via a secure online portal.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • The GenoRisk test analyzes multiple genes rather than the APOE gene alone, with results having greater predictive accuracy than other tests
+2 more records
Product overview1 text field

ADx Health is a genetic testing company offering multiple at-home and blood-based diagnostic products focused on Alzheimer's disease, pharmacogenomics, athletic performance, and gut health. The core products include GenoRisk™ Alzheimer's (genetic risk assessment via saliva test), WellMind (blood-based p-Tau217 biomarker test for early Alzheimer's detection), myGenoFit (athletic genetic testing), PGxComplete (pharmacogenomics), and BiomeIQ (gut microbiome testing). All testing is performed in their CLIA-certified and CAP-accredited laboratory in Bellingham, WA.

Product and service5 records
1GenoRisk™ Alzheimer's
CategoryGenetic Risk Assessment
Description

An at-home saliva-based genetic test that provides a polygenic risk score for late-onset Alzheimer's disease by evaluating 31 genetic variants across 23 different genes, including APOE status. Designed for adults who want to understand their genetic Alzheimer's risk, particularly those with a family history of dementia.

2WellMind
CategoryBiomarker Diagnostic Test
Description

A blood test for Alzheimer's disease that detects pathophysiological changes associated with amyloid pathology using the p-Tau217 biomarker, designed for early detection, and capable of identifying changes up to 18 years before clinical diagnosis. Customers book a blood draw appointment via the My One Medical Source phlebotomy partnership.

3myGenoFit
CategoryAthletic Genetic Testing
Description

A genetic test for athletes at any performance level that provides personalized reports on athletic ability, trainability, and injury risk, with actionable recommendations to enhance performance.

4PGxComplete
CategoryPharmacogenomic Testing
Description

An in-depth pharmacogenomics test that reviews how an individual's genetic makeup may affect their response to medications, supporting personalized medication choices.

5BiomeIQ
CategoryGut Microbiome Testing
Description

A gut microbiome testing product that provides insights into gut bacteria composition to inform personalized dietary and supplement recommendations, particularly for conditions such as IBS.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partnership for phlebotomy services to support the WellMind blood test. My One Medical Source provides draw site locations where customers can have their blood drawn for shipping to ADx Health's Bellingham, WA laboratory. Customers book appointments through My One Medical Source's platform.

2Translational Research Associates (TRAs)
Strategic tierSupportTypeImplementation/ SI/ Consulting Partner
Description

TRA's provide support to providers and patients through the Provider Portal, answering questions and providing referrals to genetic counselors as needed.

adxhealth.com
3Scientific Advisory Board Members
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Expert advisors including Robin Everts PhD (Etalon Diagnostics), Ryan Fortna MD PhD (Avero Diagnostics), Eric Hegedus PhD (Tufts University), William Kraus MD (Duke University), and Jennifer Stagg ND (Whole Health Wellness Center) providing guidance on product development and scientific research.

adxhealth.com
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

C2N Diagnostics offers the PrecivityAD blood test for Alzheimer's pathology (Aβ42/40 ratio) via clinician order, directly comparable to ADx Health's WellMind p-Tau217 blood-based early detection test for the same patient and provider audience.

TypeDirect peer
Description

23andMe is a leading direct-to-consumer genetic testing company covering health risk (including Alzheimer's via APOE), ancestry, and pharmacogenomics — overlapping ADx Health's DTC channel, kit logistics, and consumer genomics positioning.

TypeDirect peer
Description

Color Health delivers clinical-grade genetic testing for cancer, cardiovascular, and pharmacogenomics with both consumer and provider channels, overlapping ADx Health's PGxComplete offering and provider-portal-driven GTM.

TypeDirect peer
Description

Helix operates a clinical-grade DNA testing platform serving both consumers and health systems with a menu of genetic tests, comparable to ADx Health's mix of DTC kits (GenoRisk, myGenoFit) plus provider-driven testing.

5Ancestry
TypeDirect peer
Description

AncestryDNA is one of the largest DTC genetic testing brands, sharing ADx Health's e-commerce kit model, saliva-sample logistics, and consumer genomics marketing playbook.

TypeBroad incumbent
Description

Myriad Genetics is an established clinical diagnostics company offering genetic risk tests (including psychiatric and neurological risk panels) with a broader hospital and specialist channel — overlapping ADx Health's genetic testing menu at a much larger scale.

TypeBroad incumbent
Description

Quest Diagnostics is a national clinical laboratory offering genetic, pharmacogenomic, and Alzheimer's-related biomarker tests ordered through physicians — overlapping ADx Health's clinical lab service and provider-referred testing from a much larger infrastructure base.

TypeBroad incumbent
Description

Labcorp is a major clinical reference laboratory providing genetic and specialty testing including pharmacogenomics and neurological biomarkers, comparable to ADx Health's CLIA-certified lab services for both consumers and providers.

9Sema4
TypeEmerging player
Description

Sema4 (and its GeneDx oncology/reproductive health spin) operates a clinical genomic testing platform with health system and provider channels, partially overlapping ADx Health's provider-portal genetic testing approach at a smaller scale.

TypeEmerging player
Description

Genetic Technologies offers consumer and clinical polygenic risk score tests (including for breast cancer and metabolic disease), a comparable niche player in PRS-based risk assessment where ADx Health is also positioned with its GenoRisk Alzheimer's PRS.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ADx Health

Genetic Testing and Diagnostic Servicesadxhealth.com

ADx Health is a Bellingham, WA-based private genetic testing company operating a CLIA-certified laboratory, selling direct-to-consumer at-home and blood-based tests for Alzheimer's risk, pharmacogenomics, athletic performance, and gut health to consumers and referring healthcare providers.

What ADx Health does

ADx Health (legal entity: Affirmativ Diagnostics PLLC) is a privately held genetic and diagnostic testing company founded in 2016 and headquartered in Bellingham, Washington. The company operates its own CLIA-certified and CAP-accredited clinical laboratory where all testing is performed in-house, and sells primarily direct-to-consumer through an e-commerce storefront (shop.adxhealth.com), supplemented by a network of referring physicians and wellness providers who access a dedicated Provider Portal.

The product portfolio is anchored on Alzheimer's disease diagnostics and has expanded into adjacent genetic and microbiome categories. Core products include GenoRisk™, an at-home saliva-based test that uses a proprietary polygenic risk score algorithm evaluating 31 genetic variants across 23 genes (including APOE) for late-onset Alzheimer's risk; WellMind, a blood-based p-Tau217 biomarker test capable of identifying amyloid-related pathology up to 18 years before clinical diagnosis; myGenoFit (athletic performance genetics), PGxComplete (pharmacogenomics), and BiomeIQ (gut microbiome). Each purchase includes a 15-minute telehealth consultation. Underlying technology relies on DNA extraction from saliva, PCR amplification, mass spectrometry-based variant detection, and statistical cross-validation of polygenic models, supported by a peer-reviewed publication authored by Scientific Director Dr. Ryan Fortna.

The business model is one-time direct payment for test kits via e-commerce, with pay-as-you-go pricing (specific prices not publicly disclosed), bundled telehealth, and a referral-driven B2B2C layer through partner providers. The company is privately held with no disclosed funding rounds or institutional investors, operates within a U.S.-only footprint with explicit exclusions for New York state and international orders, and maintains an active content marketing and scientific advisory presence to drive demand.

ADx Health firmographics

Firmographics
Name
ADx Health
Legal name
Affirmativ Diagnostics PLLC
Website
https://adxhealth.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
ADx Health is a Bellingham, WA-based private genetic testing company operating a CLIA-certified laboratory, selling direct-to-consumer at-home and blood-based tests for Alzheimer's risk, pharmacogenomics, athletic performance, and gut health to consumers and referring healthcare providers.
Ownership category
akta.pro rank

ADx Health industry classification

Industry
Product category
Genetic Testing and Diagnostic Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

Keywords

  • Genetic testing services
  • Alzheimer's diagnostics
  • Polygenic risk scoring
  • Direct-to-consumer testing
  • Pharmacogenomic testing

Where ADx Health is headquartered

Location

Headquarters

HQ city
Bellingham
HQ country
United States
HQ region
North America

Offices2 records

Markets served

ADx Health business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

  1. Genetic Testing Kits: Direct-to-consumer sales of at-home genetic testing kits including GenoRisk Alzheimer's test, WellMind p-Tau217 blood test, myGenoFit athletic genetic test, and PGxComplete pharmacogenomics test. Customers purchase kits online and receive results through a secure portal with optional 15-minute telehealth consultation included.
  2. Telehealth Consultation Services: Optional add-on telehealth consultation with healthcare provider to review genetic testing results. Included in test purchase at no additional cost for initial 15-minute consultation.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goGenetic testing kits with included telehealth consultation

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

ADx Health product offering

Product offering

Core offering

ADx Health sells direct-to-consumer genetic testing and diagnostic kits, primarily focused on Alzheimer's disease risk assessment and early detection. Its flagship GenoRisk™ test uses a saliva sample to compute a polygenic risk score for late-onset Alzheimer's by evaluating 31 genetic variants across 23 genes, while its WellMind blood test measures the p-Tau217 biomarker to detect amyloid-pathology-related changes up to 18 years before clinical diagnosis. Additional offerings include the myGenoFit athletic genetics test, the PGxComplete pharmacogenomics test, and the BiomeIQ gut microbiome test, with each kit including a 15-minute telehealth consultation and results delivered via a secure online portal.

Product overview

ADx Health is a genetic testing company offering multiple at-home and blood-based diagnostic products focused on Alzheimer's disease, pharmacogenomics, athletic performance, and gut health. The core products include GenoRisk™ Alzheimer's (genetic risk assessment via saliva test), WellMind (blood-based p-Tau217 biomarker test for early Alzheimer's detection), myGenoFit (athletic genetic testing), PGxComplete (pharmacogenomics), and BiomeIQ (gut microbiome testing). All testing is performed in their CLIA-certified and CAP-accredited laboratory in Bellingham, WA.

Differentiator

Problem solved

Functional benefit

Brands

  • GenoRisk™ Alzheimer’s: At-home genetic test providing a polygenic risk score for late-onset Alzheimer's disease using saliva sample
  • WellMind
  • BiomeIQ
  • myGenoFit
  • PGxComplete

Products and services

  • GenoRisk™ Alzheimer's An at-home saliva-based genetic test that provides a polygenic risk score for late-onset Alzheimer's disease by evaluating 31 genetic variants across 23 different genes, including APOE status. Designed for adults who want to understand their genetic Alzheimer's risk, particularly those with a family history of dementia.
  • WellMind A blood test for Alzheimer's disease that detects pathophysiological changes associated with amyloid pathology using the p-Tau217 biomarker, designed for early detection, and capable of identifying changes up to 18 years before clinical diagnosis. Customers book a blood draw appointment via the My One Medical Source phlebotomy partnership.
  • myGenoFit A genetic test for athletes at any performance level that provides personalized reports on athletic ability, trainability, and injury risk, with actionable recommendations to enhance performance.
  • PGxComplete An in-depth pharmacogenomics test that reviews how an individual's genetic makeup may affect their response to medications, supporting personalized medication choices.
  • BiomeIQ A gut microbiome testing product that provides insights into gut bacteria composition to inform personalized dietary and supplement recommendations, particularly for conditions such as IBS.

Quantifiable outcome

  • The GenoRisk test analyzes multiple genes rather than the APOE gene alone, with results having greater predictive accuracy than other tests
  • +2 more outcomes

Companies that use ADx Health

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

ADx Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

ADx Health partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and support.

  • My One Medical SourcecoreChannel Partner/ Reseller/ DistributorPartnership for phlebotomy services to support the WellMind blood test. My One Medical Source provides draw site locations where customers can have their blood drawn for shipping to ADx Health's Bellingham, WA laboratory. Customers book appointments through My One Medical Source's platform.
  • Translational Research Associates (TRAs)supportImplementation/ SI/ Consulting PartnerTRA's provide support to providers and patients through the Provider Portal, answering questions and providing referrals to genetic counselors as needed.
  • Scientific Advisory Board MemberscoreStrategic or Co-development PartnerExpert advisors including Robin Everts PhD (Etalon Diagnostics), Ryan Fortna MD PhD (Avero Diagnostics), Eric Hegedus PhD (Tufts University), William Kraus MD (Duke University), and Jennifer Stagg ND (Whole Health Wellness Center) providing guidance on product development and scientific research.

Scale indicators4 records

Recent moves4 records

Expansion highlights5 records

ADx Health competitors and assessment

Company assessment

Direct peers

  • C2N Diagnostics: C2N Diagnostics offers the PrecivityAD blood test for Alzheimer's pathology (Aβ42/40 ratio) via clinician order, directly comparable to ADx Health's WellMind p-Tau217 blood-based early detection test for the same patient and provider audience.
  • 23andMe: 23andMe is a leading direct-to-consumer genetic testing company covering health risk (including Alzheimer's via APOE), ancestry, and pharmacogenomics — overlapping ADx Health's DTC channel, kit logistics, and consumer genomics positioning.
  • Color Health: Color Health delivers clinical-grade genetic testing for cancer, cardiovascular, and pharmacogenomics with both consumer and provider channels, overlapping ADx Health's PGxComplete offering and provider-portal-driven GTM.
  • Helix: Helix operates a clinical-grade DNA testing platform serving both consumers and health systems with a menu of genetic tests, comparable to ADx Health's mix of DTC kits (GenoRisk, myGenoFit) plus provider-driven testing.
  • Ancestry: AncestryDNA is one of the largest DTC genetic testing brands, sharing ADx Health's e-commerce kit model, saliva-sample logistics, and consumer genomics marketing playbook.

Broad incumbents

  • Myriad Genetics: Myriad Genetics is an established clinical diagnostics company offering genetic risk tests (including psychiatric and neurological risk panels) with a broader hospital and specialist channel — overlapping ADx Health's genetic testing menu at a much larger scale.
  • Quest Diagnostics: Quest Diagnostics is a national clinical laboratory offering genetic, pharmacogenomic, and Alzheimer's-related biomarker tests ordered through physicians — overlapping ADx Health's clinical lab service and provider-referred testing from a much larger infrastructure base.
  • Laboratory Corporation of America (Labcorp): Labcorp is a major clinical reference laboratory providing genetic and specialty testing including pharmacogenomics and neurological biomarkers, comparable to ADx Health's CLIA-certified lab services for both consumers and providers.

Emerging players

  • Sema4: Sema4 (and its GeneDx oncology/reproductive health spin) operates a clinical genomic testing platform with health system and provider channels, partially overlapping ADx Health's provider-portal genetic testing approach at a smaller scale.
  • Genetic Technologies (Phenogen Sciences): Genetic Technologies offers consumer and clinical polygenic risk score tests (including for breast cancer and metabolic disease), a comparable niche player in PRS-based risk assessment where ADx Health is also positioned with its GenoRisk Alzheimer's PRS.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

ADx Health social profiles

Digital presence

ADx Health compliance and trust

Trust signal

Compliance3 records

ADx Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ADx Health leadership team

Management profile

Number of profiles

Profiles5 records

ADx Health funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ADx Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ADx Health

What does ADx Health do?

ADx Health sells direct-to-consumer genetic testing and diagnostic kits, primarily focused on Alzheimer's disease risk assessment and early detection. Its flagship GenoRisk™ test uses a saliva sample to compute a polygenic risk score for late-onset Alzheimer's by evaluating 31 genetic variants across 23 genes, while its WellMind blood test measures the p-Tau217 biomarker to detect amyloid-pathology-related changes up to 18 years before clinical diagnosis. Additional offerings include the myGenoFit athletic genetics test, the PGxComplete pharmacogenomics test, and the BiomeIQ gut microbiome test, with each kit including a 15-minute telehealth consultation and results delivered via a secure online portal.

Is ADx Health a public or private company?

ADx Health is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was ADx Health founded?

ADx Health was founded in 2016. It employs 1 to 10 people.

Where is ADx Health based?

ADx Health is headquartered in Bellingham, United States, in the North America region.

How does ADx Health make money?

Two revenue lines are on record. Genetic Testing Kits are the primary driver. The others are telehealth Consultation Services.

Who are ADx Health's main competitors?

Direct peers on record are C2N Diagnostics, 23andMe, Color Health, Helix and Ancestry. Broad incumbents are Myriad Genetics, Quest Diagnostics and Laboratory Corporation of America (Labcorp). Emerging players are Sema4 and Genetic Technologies (Phenogen Sciences).

Does ADx Health have an API?

No public API is recorded for ADx Health.

What industry is ADx Health in?

ADx Health's product category is Genetic Testing and Diagnostic Services. Its primary akta.pro industry code is HLAFAMAH, Genetic & Prenatal Testing Laboratories, with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals